AppYea

AppYea Equity Growth

Delisted·Sep 22, 2026

The Year-over-Year Equity Growth of AppYea (APYP) as of Oct 29, 2026 is 413.69 %. In the previous year, Year-over-Year Equity Growth was -62.58 % — a change of -761.01% (higher).

Equity Growth

413.69 %

YoY

-761.01%

Last updated:

Year-over-Year Equity Growth of AppYea is 2025 413.69 % . Year-over-Year Equity Growth of AppYea was 2024 -62.58 % . It decreases by -761.01% higher compared to the previous year.

The AppYea Equity Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Growth
Date
Equity Growth
Jan 1, 2016
-95.30 USD
Jan 1, 2017
-760.12 USD
Jan 1, 2018
-345.45 USD
Jan 1, 2019
47.25 USD
Jan 1, 2022
-5.47 USD
Jan 1, 2023
0.94 USD
Jan 1, 2024
-62.58 USD
Jan 1, 2025
413.69 USD
The AppYea Equity Growth history
YEAREquity GrowthYoY
413.69 %-761.01%
-62.58 %-6,783.42%
0.94 %-117.11%
-5.47 %-111.58%
47.25 %-113.68%
-345.45 %-54.55%
-760.12 %+697.59%
-95.30 %-103.42%
2,790.70 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AppYea Stock analysis

What does AppYea do? AppYea Inc develops wearable monitoring solutions for sleep apnea and snoring treatment, focusing on the DreamIT wristband for snoring biofeedback and the DreamIT PRO wristband for sleep apnea treatment. The SleepX App monitors physiological parameters during sleep using algorithms developed by SleepX, while SleepX PRO is a medical application that identifies sleep apnea episodes without direct user contact. These products target patients seeking non-invasive sleep disorder management through wearable technology. The company's revenue streams come from direct sales of DreamIT, DreamIT PRO, and SleepX PRO to end-users, with the SleepX PRO app specifically positioned as a medical application for sleep apnea monitoring. The DreamIT and DreamIT PRO devices are sold alongside their respective apps, creating a bundled offering for consumers managing sleep-related health issues. The SleepX PRO app's medical certification enables it to be marketed as a healthcare solution rather than a general wellness tool. AppYea Inc's target market includes individuals diagnosed with sleep apnea or chronic snoring, who prefer wearable technology over traditional CPAP machines. The company positions its products as alternatives to conventional treatments, emphasizing convenience and non-invasive monitoring through the SleepX algorithms that process sensor data during sleep. Sales are driven by the medical application status of SleepX PRO, which differentiates it from consumer wellness apps. AppYea is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AppYea stock

Year-over-Year Equity Growth of AppYea is 413.69 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year Equity Growth AppYea since 2006 – with annual values, charts, and detailed analysis.

Equity growth measures the percentage change in shareholders' equity. It reflects retained earnings, share issuances, and comprehensive income effects.

To evaluate Year-over-Year Equity Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Equity Growth.

Year-over-Year Equity Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Equity Growth's AppYea historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — AppYea

All Key Metrics — AppYea